PCT Application No. PCT/US2012/029744 filed September 5, 2003 entitled “Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy” (HHS Ref No. E-275-2002/1-PCT-01);
Appears in 2 contracts
Samples: Patent License Agreement (Lion Biotechnologies, Inc.), Patent License Agreement (Lion Biotechnologies, Inc.)
PCT Application No. PCT/US2012/029744 US2003/027873 filed September 5, 2003 entitled “Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy” (HHS Ref No. E-275-2002/1-PCT-01);
Appears in 1 contract
Samples: Lion Biotechnologies, Inc.
PCT Application No. PCT/US2012/029744 filed September 5, 2003 entitled “Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy” (HHS Ref No. E-275-2002/1-PCT-01);; A-286-2014 NIH Patent License Agreement—Exclusive Model 10-2005 (updated 8-2012) Page 1 of 31 Final Lion Biotechnologies, Inc. February 4, 2015
Appears in 1 contract
Samples: Patent License Agreement (Lion Biotechnologies, Inc.)
